S

Spero Therapeutics

60 employees

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Novel Therapeutics
Therapeutics
Antibacterial Therapies
Infectious Disease

Date founded

2013

Funding rounds raised

Total raised

$125M

from 11 investors over 11 rounds

S

Spero Therapeutics raised $13M on January 19, 2022

Investors: Biomedical Advanced Research and Development Authority (BARDA)

S

Spero Therapeutics raised $125M on September 30, 2021

Investors: HealthCare Royalty Partners

S

Spero Therapeutics raised $5.9M on July 16, 2019

Investors: united-states-department-of-defense

S

Spero Therapeutics raised $75M on July 17, 2018

Investors: Osage University Partners (OUP)

S

Spero Therapeutics raised $6.8M on March 30, 2017

Investors: CARB-X

S

Spero Therapeutics raised $52M on March 8, 2017

Investors: Lundbeckfonden / Lundbeck Foundation, S.R. One Ltd, Atlas Venture, Osage University Partners (OUP), GV and RA Capital Management, L.P.

FAQ